MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CTKB — Cytek Biosciences, Inc. Common Stock

Nasdaq

Cytek Biosciences, Inc. Common Stock

CompareBack to Screener
$5.87
+0.06(+1.03%)
O
5.86
H
5.94
L
5.75
V
1.1M
⏱️ End-of-day dataAs of Oct 2, 2026

CTKB — Financial Statements

Historical 2-Year Statements
Financial Metric / Line ItemQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Fiscal Date2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Periodquarterlyquarterlyquarterlyquarterlyquarterlyquarterly
Year2,026.002,025.002,025.002,025.002,025.002,024.00
Cash31,806.0028,983.0031,256.0026,582.0019,497.0032,251.00
Cash Equivalents33,859.0061,870.0062,025.0048,888.0075,801.0066,465.00
Cash And Cash Equivalents65,665.0090,853.0093,281.0075,470.0095,298.0098,716.00
Other Short Term Investments196,560.00170,676.00168,453.00186,552.00170,314.00179,145.00
Accounts Receivable51,903.0062,509.0056,632.0056,232.0055,029.0060,588.00
Other Receivables3,558.004,208.004,309.00N/AN/AN/A
Inventory49,791.0048,428.0051,649.0049,487.0045,347.0043,893.00
Prepaid Assets7,206.006,935.0010,516.0011,886.0012,049.0012,132.00
Other Current Assets3,602.002,977.002,917.002,762.002,286.001,943.00
Total Current Assets379,302.00391,996.00388,489.00382,825.00380,501.00396,446.00
Properties22,566.0023,192.0023,448.0028,444.0021,618.0021,807.00
Machinery Furniture Equipment5,682.005,409.005,136.004,158.003,880.003,693.00
Construction In Progress4,215.001,417.00845.001,449.00654.00357.00
Leases3,693.003,518.003,607.003,622.003,572.003,224.00
Accumulated Depreciation-13,057.00-12,134.00-11,608.00-10,662.00-9,644.00-8,714.00
Goodwill49,082.0050,215.0051,072.0052,015.0052,787.0053,454.00
Intangible Assets15,704.0016,821.0017,676.0018,601.0019,431.0020,128.00
Other Non Current Assets6,306.006,704.0042,852.0040,448.0038,283.0038,133.00
Total Non Current Assets69,811.0069,546.00106,430.00110,495.00102,094.00103,054.00
Total Assets449,113.00461,542.00494,919.00493,320.00482,595.00499,500.00
Accounts Payable6,741.006,410.007,632.006,853.006,247.005,529.00
Accrued Expenses11,710.008,225.006,978.007,966.008,309.006,678.00
Short Term Debt13,655.009,176.0010,677.008,769.007,531.008,414.00
Deferred Revenue31,179.0029,572.0029,780.0030,010.0028,749.0026,610.00
Tax Payable7,031.006,283.004,349.003,550.004,109.003,559.00
Pensions8,071.0015,192.0013,254.0013,638.0010,888.0014,765.00
Other Current Liabilities2,548.002,946.002,537.002,484.001,858.002,108.00
Total Current Liabilities80,935.0077,804.0075,207.0073,270.0067,691.0067,663.00
Long Term Debt13,827.0014,567.0014,149.0014,910.008,366.008,602.00
Other Non Current Liabilities9,035.009,093.0010,677.0010,958.0011,199.0011,400.00
Total Non Current Liabilities40,534.0041,999.0041,141.0042,493.0035,282.0036,100.00
Total Liabilities121,469.00119,803.00116,348.00115,763.00102,973.00103,763.00
Common Stock129.00129.00128.00127.00128.00129.00
Retained Earnings-120,604.00-101,738.00-57,662.00-52,184.00-46,601.00-35,199.00
Other Shareholders Equity2,369.002,241.00821.00-38.00-609.0016.00
Total Shareholders Equity327,644.00341,739.00378,571.00377,557.00379,623.00395,737.00
Additional Paid In Capital445,750.00441,107.00435,284.00429,652.00426,705.00430,791.00
Restricted CashN/A0.000.000.000.0029.00
Minority InterestN/A0.00N/AN/AN/A0.00